Literature DB >> 4004627

Rhegmatogenous retinal detachment in Labrador retrievers. I. Development of retinal tears and detachment.

N P Blair, J T Dodge, G M Schmidt.   

Abstract

We used clinical and pathologic methods to examine ten Labrador retrievers with ocular and skeletal abnormalities. The major ocular findings were axial myopia; cataract; vitreous abnormalities, including liquefaction, detachment, and vitreoretinal traction; retinal tears; rhegmatogenous retinal detachment; and proliferative vitreoretinopathy. The appendicular skeleton showed retarded bone growth, bone dysplasia, and degenerative arthropathy. Vitreoretinal traction appeared to be the cause of the retinal tears because (1) formed vitreous was always attached near the anterior edge of the tear, and (2) vitreous traction caused a retinal ridge adjacent to a retinal tear in a dog that had not yet developed retinal detachment. The pathogenetic sequence of spontaneous vitreous abnormalities, retinal tears, and retinal detachment observed in these dogs has not previously been described in animals, to the best of our knowledge, and mimicked human rhegmatogenous retinal detachment, particularly those associated with giant retinal tears.

Entities:  

Mesh:

Year:  1985        PMID: 4004627     DOI: 10.1001/archopht.1985.01050060102037

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  3 in total

1.  Diagnostic ophthalmology.

Authors:  B Grahn; J Wolfer; C Wheler
Journal:  Can Vet J       Date:  1996-01       Impact factor: 1.008

2.  Ocular-chondrodysplasia in labrador retriever dogs: a morphometric and electron microscopical analysis.

Authors:  C E Farnum; K Jones; R Riis; N J Wilsman
Journal:  Calcif Tissue Int       Date:  1992-06       Impact factor: 4.333

3.  Clinical, histopathological and genetic characterisation of oculoskeletal dysplasia in the Northern Inuit Dog.

Authors:  Renata Stavinohova; Claudia Hartley; Louise M Burmeister; Sally L Ricketts; Louise Pettitt; Roser Tetas Pont; Rebekkah J Hitti; Ellen Schofield; James A C Oliver; Cathryn S Mellersh
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.